• M. Inés Klein; Eduardo Bergel; Luz Gibbons; Silvina Coviello; Gabriela Bauer; Alicia Benitez ; M. Elina Serra; M. Florencia Delgado; Guillermina A. Melendi; Susana Rodriguez; Steven R. Kleeberger; Fernando P. Polack. Differential gender response to respiratory infections and to the protective effect of breast milk in premature infants. Pediatrics. 2007 (In Press).
• Melendi GA, Zavala F, Buchholz UJ, Boivin G, Collins PL, Kleeberger SR. Mapping and characterization of the primary and anamnestic H-2(d)-restricted cytotoxic T-lymphocyte response in mice against human metapneumovirus. J Virol. 2007 Oct;81(20):11461-7. Descargar en PDF.
• Melendi GA, Laham FR, Monsalvo AC, Casellas JM, Israele V, Polack NR, Kleeberger SR, Polack FP. Cytokine profiles in the respiratory tract during primary infection with human metapneumovirus, respiratory syncytial virus, or influenza virus in infants. Pediatrics. 2007 Aug;120(2):e41. Descargar en PDF.
• Polack Fernando P. Atypical measles and enhanced respiratory syncytial virus disease (ERD) made simple. Pediatr Res. 2007 Jul;62(1):111-5. Descargar en PDF.
• Melendi GA, Hoffman SJ, Karron RA, Irusta PM, Laham FR, Humbles A, Schofield B, Pan CH, Rabold R, Thumar B, Thumar A, Gerard NP, Mitzner W, Barnum SR, Gerard C, Kleeberger SR, Polack FP. C5 modulates airways hyperreactivity and pulmonary eosinophilia during enhanced respiratory syncytial virus disease by decreasing C3a receptor expression. J Virol. 2007 Jan;81(2):991-9. Descargar en PDF.
• Klein MI, Coviello S, Bauer G, Benitez A, Serra ME, Schiatti MP, Delgado MF, Melendi GA, Novalli L, Pena HG, Karron RA, Kleeberger SR, Polack FP. The Impact of Infection with Human Metapneumovirus and Other Respiratory Viruses in Young Infants and Children at High Risk for Severe Pulmonary Disease. J Infect Dis. 2006;193:1544-51.
Descargar en PDF.
• Bukreyev A, Serra ME, Laham FR, Melendi GA, Kleeberger SR, Collins PL, Polack FP. The Cysteine-Rich Region and Secreted Form of the Attachment G Glycoprotein of Respiratory Syncytial Virus Enhance the Cytotoxic T-Lymphocyte Response despite Lacking Major Histocompatibility Complex Class I-Restricted Epitopes. J Virol. 2006; 80:5854-61. Descargar en PDF.
• Polack FP, Irusta PM, Hoffman SJ, Schiatti MP, Melendi GA, Delgado MF, Laham FR, Thumar B, Hendry RM, Melero JA, Karron RA, Collins PL, Kleeberger SR. The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxin. Proc Natl Acad Sci U S A. 2005;102:8996-9001. Descargar en PDF.
• Coviello S & Polack FP. Prophylactic and Therapeutic Approaches Against Respiratory Syncytial Virus. Curr Med Chem-Anti-Infect Agents 2005; 4:67-73. Descargar en PDF.
• Delgado MF & Polack FP. Involvement of antibody, complement and cellular immunity in the pathogenesis of enhanced respiratory syncytial virus disease. Expert Rev Vaccines. 2004;3:693-700. Descargar en PDF.
• Laham FR, Israele V, Casellas JM, Garcia AM, Lac Prugent CM, Hoffman SJ, Hauer D, Thumar B, Name MI, Pascual A, Taratutto N, Ishida MT, Balduzzi M, Maccarone M, Jackli S, Passarino R, Gaivironsky RA, Karron RA, Polack NR, Polack FP. Differential Production of Inflammatory Cytokines in Primary Infection with Human Metapneumovirus and with Other Common Respiratory Viruses of Infancy. J Infect Dis. 2004;189:2047-56. Descargar en PDF.
• Hoffman SJ, Laham FR, Polack FP. Mechanisms of illness during respiratory syncytial virus infection: the lungs, the virus and the immune response. Microbes Infect. 2004;6:767-72. Descargar en PDF.
